PET/MRI scanning in pre-surgical staging of high-risk prostate cancer patients

A small, Norwegian, Phase II clinical trial has explored the potential diagnostic value of [18F]fluciclovine PET/MRI scans of the pelvic lymph nodes in staging for patients with high-risk prostate cancer. … READ MORE …

Potential new imaging agent in diagnosis, monitoring of prostate cancer

About 19 months ago we reported that a company called Progenics Pharmaceuticals had acquired all rights to a small, radiolabeled molecule known as [99mTc]MIP-1404, and that an international, multi-center Phase II trial was  investigating the clinical activity of [99mTc]MIP-1404 as a prostate cancer imaging agent. … READ MORE …

New NCCN guidelines on prostate cancer are not an all-around success!

Alas, the latest revisions to the National Comprehensive Cancer Network (NCCN) guidelines on early detection of prostate cancer seem to have instigated more furore than they have clarity (although the original premise behind them may have been well intentioned). … READ MORE …

Prostate Cancer Roundtable endorses statement on early detection in men at high risk

The Prostate Cancer Roundtable has endorsed a statement developed by the Prostate Health Education Network (PHEN) on the role of PSA testing in the early detection of prostate cancer among men acknowledged to be at elevated risk. … READ MORE …

GE heads up $1 billion cancer detection and treatment plan

If you have a really innovative idea that might impact the diagnosis and treatment of prostate cancer, now’s the time to get your proposal in to GE and its venture capital partners. … READ MORE …

Better ultrasound technology in diagnosis … is it time for change?

For many years a relatively small group of specialists have argued that “enhanced” types of transrectal ultrasound technology (most specifically inclusive of color Döppler ultrasound) have a greater ability to identify possible signs of prostate cancer than traditional “gray-scale” ultrasound. … READ MORE …

As Us TOO International turns 20

In early 1990, Dr. Gerry Chodak — a well-known Chicago-based urologist and then professor of urology at The University of Chicago — wrote a letter to his prostate cancer patients. He said that some of them were interested in starting a prostate cancer support group. From such small beginnings … … READ MORE …